Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Arteries of the Lower Limbs

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

Seizures: Classification

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine learning-based diagnostic model for neonatal intestinal diseases in multiple centres: a cross-sectional study protocol.

BMJ open·2025

Same author

Advances in genetic developmental and epileptic encephalopathies with movement disorders.

Acta epileptologica·2025

Same author

Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review.

Molecular genetics & genomic medicine·2022

Same author

Rare variant of TBL1XR1 in West syndrome: A case report.

Molecular genetics & genomic medicine·2022

Same author

Hypertensive disorders in pregnancy and risk of asthma in offspring: a systematic review and meta-analysis.

BMJ open·2021

Same author

Arterial spin labeling for presurgical localization of refractory frontal lobe epilepsy in children.

European journal of medical research·2021

Search research articles

Related Experiment Video

Updated: May 14, 2025

Pentylenetetrazole-Induced Kindling Mouse Model

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Genetic mechanisms in generalized epilepsies.

Xiaoqian Wang^1,2, Xueyi Rao^1,2, Jia Zhang^1,2

¹Department of Pediatrics, West China Second University Hospital, Sichuan University, No. 20, Section Three, South Renmin Road, Chengdu, 610041, China.

Acta Epileptologica

|April 11, 2025

Summary

Genetic generalized epilepsies (GGEs) stem from genetic factors. This review explores current genetic mechanisms, focusing on reliable gene identification for GGE to advance understanding.

Keywords:

Copy number variations Genetic generalized epilepsies Genetic mechanism Susceptibility gene

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Related Experiment Videos

Last Updated: May 14, 2025

Pentylenetetrazole-Induced Kindling Mouse Model

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Area of Science:

Neuroscience
Genetics
Medical Genetics

Background:

Genetic generalized epilepsies (GGEs) are known to have a genetic basis, supported by twin and family studies.
The genetic underpinnings of GGEs are complex and continuously evolving with new discoveries.
Advancements in genetic research frequently identify novel susceptibility genes and copy number variations.

Purpose of the Study:

To review and discuss the important, up-to-date genetic mechanisms contributing to GGEs.
To clarify the criteria for identifying reliable GGE-associated genes amidst evolving research and resources like ClinGen.
To enhance the understanding of the genetic etiology of GGEs.

Main Methods:

Literature review of recent genetic studies on GGEs.
Analysis of findings related to susceptibility genes and copy number variations.
Discussion of gene validation processes and the impact of resources like ClinGen.

Main Results:

Identification of emerging genetic factors implicated in GGE.
Evaluation of the evidence supporting candidate genes for GGE.
Highlighting the challenges and progress in establishing reliable genetic markers for GGE.

Conclusions:

Understanding the genetic basis of GGEs requires continuous evaluation of evidence for candidate genes.
Reliable gene identification is crucial for advancing GGE research and clinical applications.
This review synthesizes current knowledge on GGE genetic mechanisms, aiding future research directions.